{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Eli Lilly", "item": "https://www.patentleaderboard.com/company/lilly"}, {"@type": "ListItem", "position": 3, "name": "Robert Theodore Vasileff", "item": "https://www.patentleaderboard.com/inventor/fl:ro_ln:vasileff-1"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
RV

Robert Theodore Vasileff — 13 Patents

Eli Lilly: 13 patents #248 of 2,858Top 9%
Indianapolis, IN: #458 of 5,011 inventorsTop 10%
Indiana: #2,741 of 33,936 inventorsTop 9%
Overall (All Time): #362,438 of 4,157,543Top 9%
13 Patents All Time
Robert Theodore Vasileff has been granted 13 US patents while listed as an inventor at Eli Lilly. The first was granted in 1983 and the most recent in March 2004. Robert Theodore Vasileff ranks #362,438 of 4,157,543 US inventors in our database (top 8.7%). Patent records list Robert Theodore Vasileff in Indianapolis, IN, US.

Patents per Year

Patents granted per year, 1983 to 2004Bar chart with a peak of 3 patents in 2000.peak 31983: 1 patents19831985: 1 patents19851986: 1 patents19861989: 1 patents19891997: 1 patents19971998: 1 patents19982000: 3 patents20002001: 1 patents20012002: 2 patents20022004: 1 patents2004

Issued Patents All Time

Showing 1–13 of 13 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
6713645 Substituted tricyclics Nicholas J. Bach, Susan E. Draheim, Robert D. Dillard, Edward David Mihelich, Jason Scott Sawyer +17 more 2004-03-30 $108,187,000
6472405 Glycoprotein IIB/IIIA antagonists Matthew Joseph Fisher, Anne Marie Happ, Joseph A. Jakubowski, Michael Dean Kinnick, Allen D. Kline +3 more 2002-10-29 $136,068,000
6448269 Glycoprotein IIb/IIIa antagonists Matthew Joseph Fisher, Anne Marie Happ, Joseph A. Jakubowski, Michael Dean Kinnick, Allen D. Kline +9 more 2002-09-10 $109,326,000
6177440 Substituted tricyclics Nicholas J. Bach, Susan E. Draheim, Robert D. Dillard, Edward David Mihelich, Jason Scott Sawyer +17 more 2001-01-23 $624,202,000
6137002 Glycoprotein IIb/IIIa antagonists Matthew Joseph Fisher, Anne Marie Happ, Joseph A. Jakubowski, Michael Dean Kinnick, Allen D. Kline +3 more 2000-10-24 $660,415,000
6020362 Glycoprotein IIB IIIA antagonists Matthew Joseph Fisher, Anne Marie Happ, Joseph A. Jakubowski, Michael Dean Kinnick, Allen D. Kline +9 more 2000-02-01 $115,050,000
6013674 Cell adhesion inhibitors John Michael Morin, Jr., Michael Dean Kinnick, William T. Jackson 2000-01-11 $325,009,000
5731324 Glycoprotein IIb/IIIa antagonists Matthew Joseph Fisher, Anne Marie Happ, Joseph A. Jakubowski, Michael Dean Kinnick, Allen D. Kline +9 more 1998-03-24 $70,695,000
5618843 Glycoprotein IIb/IIIa antagonists Matthew Joseph Fisher, Anne Marie Happ, Joseph A. Jakubowski, Michael Dean Kinnick, Allen D. Kline +3 more 1997-04-08 $45,283,000
4888100 Photochemical conversion of cephalosporins, 1-carba(1-dethia)cephalosporins and 1-oxa(1-dethia)cephalosporins Larry W. Hertel, John Michael Morin, Jr. 1989-12-19 $70,941,000
4577014 Thieno and furopyridinium-substituted cephalosporins William H. W. Lunn 1986-03-18 $27,753,000
4501739 Thieno and furopyridinium-substituted cephalosporins William H. W. Lunn 1985-02-26 $3,083,000
4406898 Oxazole and oxadiazole cephalosporins William H. W. Lunn 1983-09-27 $24,892,000